US Covid-19 vaccine working well on monkeys

  • 📰 theSundaily
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

Malaysia Headlines News

Malaysia Latest News,Malaysia Headlines

WASHINGTON: US biotech firm Moderna’s COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses an...

US biotech firm Moderna’s COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England Journal of Medicine said Tuesday.

In the Moderna animal study, three groups of eight rhesus macaques received either a placebo or the vaccine at two different dose levels -- 10 micrograms and 100 micrograms. The authors reported that the vaccine also induced the production of a different immune cell known as T-cells that may have helped boost the overall response.

Four weeks after the monkeys received their second injection, they were exposed to the SARS-CoV-2 virus, both through the nose and directly to the lungs via a tube. A COVID-19 vaccine capable of stopping the virus in the lungs will prevent the disease from becoming severe, while stopping the virus from replicating in the nose would lessen transmission.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 25. in MY

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US doubles investment on potential Covid-19 vaccine to nearly US$1 bilUS biotech firm Moderna expects to produce 500 million doses a year starting in 2021. FMTNews Vaccine Covid19 US
Source: fmtoday - 🏆 5. / 72 Read more »

Emergent signs US$174m deal to make AstraZeneca’s potential Covid-19 vaccine | Malay MailLONDON, July 27 — Emergent BioSolutions Inc said today it signed a US$174 million (RM739.9 million) agreement with AstraZeneca to develop and manufacture the British drugmaker’s Covid-19 vaccine candidate. AstraZeneca in June picked Emergent to help produce 300 million doses of its potential...
Source: malaymail - 🏆 1. / 86 Read more »

US Republicans unveil Covid-19 plan, slash emergency unemployment benefitWASHINGTON: Senate Republicans on Monday proposed a US$1 trillion coronavirus aid package hammered out with the White House, paving the way for talks ...
Source: theSundaily - 🏆 25. / 51 Read more »

US manufacturing sector regaining momentum, rising Covid-19 threatens recovery | Malay MailWASHINGTON, July 28 — New orders for key US-made capital goods increased by the most in nearly two years in June and shipments accelerated, but the gains were likely insufficient to avert the deepest plunge in business investment and economic activity since the Great Depression in the second...
Source: malaymail - 🏆 1. / 86 Read more »

US consumer confidence dims in July as Covid-19 pandemic intensifiesWASHINGTON: US consumer confidence deteriorated in July as the coronavirus pandemic intensified, with the short-term outlook for business conditions, ...
Source: theSundaily - 🏆 25. / 51 Read more »

US durable good orders continue Covid-19 recovery in JuneWASHINGTON: US durable good orders in June continued their recovery from the Covid-19 hit, with new orders rising 7.3% on demand for transportation eq...
Source: theSundaily - 🏆 25. / 51 Read more »